Results 261 to 270 of about 5,734,618 (390)

Effects of Dalcroze Eurhythmics Exercise Versus Multicomponent Exercise on Physical and Cognitive Function, and Falls in Older Adults: The EPHYCOS Randomized Controlled Trial

Advanced Biology, EarlyView.
In this randomized clinical trial conducted among 142 community‐dwelling older adults at high risk for falls over 12 months, a Dalcroze Eurhythmics exercise intervention (once weekly, group‐based) improved a variety of physical and cognitive/executive function outcomes compared with a multicomponent exercise intervention (twice weekly, group‐ and home ...
Mélany Hars, Natalia Fernandez, François Herrmann, René Rizzoli, Serge Ferrari, Christophe Graf, Patrik Vuilleumier, Andrea Trombetti   +7 more
wiley   +1 more source

Study finds adverse events in 3% of hospital patients; ADEs rank second [PDF]

, 2000
Nancy Tarleton Landis
openalex   +1 more source

Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective

British medical journal, 2016
N. Lineberry, J. Berlin, Bernadette Mansi, Susan Glasser, M. Berkwits, Christian Klem, Ananya Bhattacharya, L. Citrome, R. Enck, J. Fletcher, Daniel G Haller, Tai-Tsang Chen, C. Laine   +12 more
semanticscholar   +1 more source

Current and Future Cornea Chip Models for Advancing Ophthalmic Research and Therapeutics

Advanced Biology, EarlyView.
This review analyzes cornea chip technology as an innovative solution to corneal blindness and tissue scarcity. The examination encompasses recent developments in biomaterial design and fabrication methods replicating corneal architecture, highlighting applications in drug screening and disease modeling while addressing key challenges in mimicking ...
Minju Kim, Kanghoon Choi, Amy Lin, Jungkyu Kim   +3 more
wiley   +1 more source

Romosozumab adverse event profile: a pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) from 2019 to 2023. [PDF]

Aging Clin Exp Res
Liu L, Wu S, Wei L, Xia Z, Ji J, Huang D.   +5 more
europepmc   +1 more source

The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead

Advanced Biology, EarlyView.
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi, Anjali Kumari, Samaneh Ghadami, Saqer Al Abdullah, Kristen Dellinger   +4 more
wiley   +1 more source

Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events

, 2000
Mariann Gyöngyösi, Paul Yang, Aliasghar Khorsand, Dietmar Glogar   +3 more
openalex   +1 more source

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database. [PDF]

Front Pharmacol
Tian Y, Jin M, Ning H.
europepmc   +1 more source

Adverse events in British hospitals: preliminary retrospective record review [PDF]

, 2001
Charles Vincent
openalex   +1 more source

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Vaccine, 2015
T. Shimabukuro, M. Nguyen, David Martin, F. Destefano   +3 more
semanticscholar   +1 more source